Literature DB >> 31564476

[Impact of nutrition on breast cancer mortality and risk of recurrence, a review of the evidence].

Louise Maumy1, Guillaume Harrissart1, Pauline Dewaele1, Ahmed Aljaber1, Claire Bonneau2, Roman Rouzier2, Antoine Eliès3.   

Abstract

INTRODUCTION: There is a growing interest in diets and their effects on cancer prognosis. In 2014, a report from the World Cancer Research Fund on diet and women with a history of breast cancer did not demonstrate a major effect on breast cancer prognosis. The aim of this literature review was to provide an update of knowledge in this area.
METHODS: Randomized trials, prospective cohorts and meta-analyses published between 2012 and 2018 examining the impact of diet on recurrence risk and/or mortality after breast cancer were included, to achieve the objective. We evaluated study quality (according to Haute Autorité de Santé criteria) and the studied diets were categorized: macronutrients, micronutrients and selective foods.
RESULTS: We selected eighteen articles that met levels of evidence 1 to 3. For macronutrients, a low-fat diet was associated with better survival. With regard to micronutrients, a diet rich in phytœstrogen reduced the risk of cancer recurrence. Finally, the adoption of a healthy diet was not associated with an improved prognosis for breast cancer but with an improvement in overall survival and risk of death from cardiovascular disease. DISCUSSION: This review suggests that nutrition influences the prognosis of breast cancer. Nevertheless, the level of evidence of the results was insufficient to make recommendations. Ultimately, a healthy and balanced diet could be encouraged in order to reduce global mortality.
Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer du sein; Diet; Prognostic; Pronostic; Prévention secondaire; Régime; Secondary prevention; Survie; Survival

Mesh:

Substances:

Year:  2019        PMID: 31564476     DOI: 10.1016/j.bulcan.2019.08.009

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  7 in total

1.  STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling.

Authors:  Peina He; Jianyun Sheng; Jinxu Qi; Xianguang Bai; Jiaxin Li; Fubao Wang; Yamin Yuan; Xinhua Zheng
Journal:  Mol Biol Rep       Date:  2021-11-30       Impact factor: 2.316

2.  [Association of nutritional status with clinical outcomes of stroke patients with acute anterior circulation large vessel occlusion after emergency endovascular treatment].

Authors:  Y Sun; Y Ji; K Wu; H Wang; Y Guo; X Xu; X Shang; Q Yang; X Huang; Z Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

Review 3.  Dietary phytochemicals/nutrients as promising protector of breast cancer development: a comprehensive analysis.

Authors:  Suman Kumar Samanta; Paramita Choudhury; Partha Pratim Sarma; Bhaskarjyoti Gogoi; Neelutpal Gogoi; Rajlakshmi Devi
Journal:  Pharmacol Rep       Date:  2022-06-04       Impact factor: 3.919

Review 4.  Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature).

Authors:  Beata Smolarz; Anna Zadrożna Nowak; Hanna Romanowicz
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

5.  Integrative Cancer Therapies: Learning From COVID-19.

Authors:  Keith I Block
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

6.  Diet quality is associated with primary melanoma thickness.

Authors:  M C B Hughes; M Malt; K Khosrotehrani; B M Smithers; A C Green
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-07       Impact factor: 9.228

7.  Vitamin D and Histological Features of Breast Cancer: Preliminary Data from an Observational Retrospective Italian Study.

Authors:  Stefano Lello; Anna Capozzi; Lorenzo Scardina; Lucia Ionta; Roberto Sorge; Giovanni Scambia; Gianluca Franceschini
Journal:  J Pers Med       Date:  2022-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.